SIBN Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
56.0M
+6.5%
52.6M
-6.7%
56.3M
+15.8%
48.7M
+0.1%
48.6M
Cost of Revenue
11.5M
+7.7%
10.6M
-9.9%
11.8M
+20.5%
9.8M
-0.1%
9.8M
Gross Profit
44.5M
+6.2%
41.9M
-5.8%
44.5M
+14.6%
38.8M
+0.1%
38.8M
Operating Expenses
49.4M
+4.9%
47.0M
+0.1%
47.0M
+6.3%
44.2M
-3.5%
45.8M
R&D
5.2M
+24.5%
4.2M
-3.9%
4.4M
+2.9%
4.2M
-1.6%
4.3M
SG&A
44.1M
+3.0%
42.8M
+0.5%
42.6M
+6.6%
40.0M
-3.7%
41.5M
Operating Income
-4806000
+5.6%
-5093000
-106.8%
-2463000
+54.2%
-5383000
+23.1%
-7004000
EBITDA
-3127000
+10.0%
-3476000
-321.3%
-825000
+81.8%
-4525000
+19.7%
-5636000
Net Income
-4088000
+5.7%
-4334000
-163.6%
-1644000
+64.0%
-4566000
+25.8%
-6152000
EPS (Basic)
$-0.09
+10.0%
$-0.10
-150.0%
$-0.04
+63.6%
$-0.11
+21.4%
$-0.14
EPS (Diluted)
$-0.09
+10.0%
$-0.10
-150.0%
$-0.04
+63.6%
$-0.11
+21.4%
$-0.14
Shares (Diluted)
44.5M
+1.2%
44.0M
+1.0%
43.5M
+0.8%
43.2M
+0.9%
42.8M
SI-BONE (SIBN) โ€” Financials